Kenneth L. Custer
Direttore/Membro del Consiglio presso Jaguar Gene Therapy LLC
Provenienza dei contatti di primo grado di Kenneth L. Custer
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a clinical stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company has a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. Jaguar is rapidly advancing an initial pipeline of three programs, including targeting severe neurodevelopmental disorders, type 1 galactosemia, and type 1 diabetes. The company partner with Advanced Medicine Partners for manufacturing their therapeutics. Key investors include Deerfield Management Company, Arch Venture Partners, and Eli Lilly and Company. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020.
10
| Holding Company | Medical/Nursing Services | 10 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Kenneth L. Custer tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Operating Officer | |
Deerfield Management Co. LP
 Deerfield Management Co. LP Investment ManagersFinance Deerfield Management Co. LP (Deerfield) is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Peter Drake in 1994. They are wholly owned by James E. Flynn and are controlled by its general partner, Flynn Management LLC. Deerfield provides discretionary investment management services in the healthcare sector to domestic and offshore private pooled investment vehicles and their related alternative investment vehicles. | Investment Managers | Analyst-Equity | |
| University of Nebraska | College/University | Graduate Degree | |
| VENTAS, INC. | Real Estate Investment Trusts | Director/Board Member | |
Citigroup Global Markets, Inc. (Broker)
 Citigroup Global Markets, Inc. (Broker) Investment Banks/BrokersFinance Citigroup Global Markets, Inc. (Broker) (CGMI-Broker) is the broker/dealer division of Citigroup Global Markets, Inc., an investment bank headquartered in New York City with additional offices across the US. The firm was founded in 2004 and is a subsidiary of Citigroup Financial Products, Inc., ultimately held by Citigroup, Inc. (NYSE: C). CGMI-Broker covers all market capitalizations of the major global indices and provides macro and quantitative analysis of global markets and sector trends. Their core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis. | Investment Banks/Brokers | Analyst-Equity | |
| INTERMUNE INC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
OcuNexus Therapeutics, Inc.
 OcuNexus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuNexus Therapeutics, Inc. develops and commercializes therapeutic products for wound care and tissue repair. The firm offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was founded in 2005 by David Lawrence Becker, Colin C. Green and Bradford J. Duft and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Deerfield Management Co. LP (Private Equity)
 Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| TERNS PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | Chief Executive Officer | |
Lundbeck, Inc.
 Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | Pharmaceuticals: Major | President | |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Biotechnology | Chairman | |
Encoded Therapeutics, Inc.
 Encoded Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Chairman | |
| Nolan Capital LLC | Chairman | ||
| John Carroll University | College/University | Director/Board Member | |
| WEREWOLF THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
| BIOMX INC. | Biotechnology | Director/Board Member | |
| Columbia University Medical Center | College/University | Director/Board Member | |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Biotechnology | Chairman | |
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II | Financial Conglomerates | Director/Board Member | |
| University of Maryland | College/University | Undergraduate Degree | |
| Tufts University School of Medicine | College/University | Doctorate Degree | |
Relay Technology Management, Inc.
 Relay Technology Management, Inc. Miscellaneous Commercial ServicesCommercial Services Relay Technology Management is a life sciences business intelligence software provider founded in 2008 with one core belief that enabling data-driven decision-making via objective, standard asset valuation and trend analytics will lead to increased efficiency in drug development. Data-driven decision-making in turn will lead to cures for patients around the world becoming available faster. The Relay Innovation Engine software platform powers the Business Development Live software-as-a-service and their strategy consulting practice, which supports business development and corporate strategy professionals by aggregating scientific, business and medical data in an actionable context. Relay works with life science companies to increase the efficiency of drug development by offering a transparent, objective and scalable approach to business intelligence and analytics. Relay was founded by David Greenwald, Ph.D. and Brigham Hyde, Ph.D. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Johns Hopkins Technology Ventures | Director/Board Member | ||
| HILLEVAX, INC. | Biotechnology | Director/Board Member | |
Cirius Therapeutics, Inc.
 Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| UCLA Anderson School of Management | College/University | Masters Business Admin | |
| Concordia University | College/University | Undergraduate Degree | |
| ARS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ATHERSYS, INC. | Biotechnology | Director/Board Member | |
Eversana Life Science Services LLC
 Eversana Life Science Services LLC Miscellaneous Commercial ServicesCommercial Services EVERSANA Life Science Services LLC engages in the provision of global services to the life science industry. It offers pricing, reimbursement and market access, global channel management, revenue management, and affordability programs. The company is headquartered in Milwaukee, WI. | Miscellaneous Commercial Services | President | |
| Tulane University (Louisiana) | College/University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 42 |
| Canada | 3 |
| Svizzera | 2 |
| Cina | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 25 |
| Consumer Services | 11 |
| Finance | 8 |
| Commercial Services | 5 |
Posizioni
| Director/Board Member | 72 |
| Independent Dir/Board Member | 21 |
| Corporate Officer/Principal | 17 |
| Chairman | 9 |
| Chief Executive Officer | 8 |
Contatti più connessi
| Insiders | |
|---|---|
| Jonathan Leff | 45 |
| Sean Nolan | 18 |
| David Fellows | 16 |
| Andrew Knudten | 11 |
| Elise T. Wang | 10 |
| Joseph Nolan | 9 |
| David Greenwald | 8 |
| Elise Wang | 5 |
| Dave Greenwald | 2 |
| Dave Fellows | 1 |
- Borsa valori
- Insiders
- Kenneth L. Custer
- Connessioni Società
